Skip to content
  • Join Us
  • Members Area
ASOI
  • Home
  • ASOI News
  • About Us
  • Events
  • Media Resources
  • Public Resources
  • Guidelines
  • Research

Publication Category: Metabolic Health

Simulation of gastric bypass effects on glucose metabolism and non-alcoholic fatty liver disease with the Sleeveballoon device

  • J. Casella-Mariolo; L. Castagneto-Gissey; G. Angelini; A. Zoli; P. Marini; S. R. Bornstein; D. J. Pournaras; F. Rubino; C. W. le Roux; G. Mingrone; G. Casella Simulation of gastric bypass effects on glucose metabolism and non-alcoholic fatty liver disease with the Sleeveballoon device EBioMedicine

    Insulin Resistance & Diabetes NAFLD

Improvements in diabetic albuminuria and podocyte differentiation following Roux-en-Y gastric bypass surgery

  • A. L. Canney; R. V. Cohen; J. A. Elliott; M. A. C; W. P. Martin; N. G. Docherty; C. W. le Roux Improvements in diabetic albuminuria and podocyte differentiation following Roux-en-Y gastric bypass surgery Diab Vasc Dis Res

    Insulin Resistance & Diabetes

Dipeptidyl peptidase-4 activity, lipopolysaccharide, C-reactive protein, glucose metabolism, and gut peptides 3 months after bariatric surgery

  • T. G. Braga; M. D. Graças Coelho de Souza; M. Menezes; J. F. Nogueira Neto; L. Dellatorre-Teixeira; E. Bouskela; C. W. le Roux; L. G. Kraemer-Aguiar Dipeptidyl peptidase-4 activity, lipopolysaccharide, C-reactive protein, glucose metabolism, and gut peptides 3 months after bariatric surgery Surg Obes Relat Dis

    Gut-Brain Insulin Resistance & Diabetes

Options in Bariatric Surgery: Modeled Decision Analysis Supports One-Anastomosis Gastric Bypass as the Treatment of Choice when Type 2 Diabetes Is Present

  • C. Brosnan; J. C. Bolger; E. M. Bolger; M. E. Kelly; R. Tully; M. AlAzzawi; W. B. Robb Options in Bariatric Surgery: Modeled Decision Analysis Supports One-Anastomosis Gastric Bypass as the Treatment of Choice when Type 2 Diabetes Is Present Obes Surg

    Insulin Resistance & Diabetes

Potential gut-brain mechanisms behind adverse mental health outcomes of bariatric surgery

  • R. M. Brown; E. Guerrero-Hreins; W. A. Brown; C. W. le Roux; P. Sumithran Potential gut-brain mechanisms behind adverse mental health outcomes of bariatric surgery Nat Rev Endocrinol

    Gut-Brain

Changes in Bile Acid Profile After Laparoscopic Sleeve Gastrectomy are Associated with Improvements in Metabolic Profile and Fatty Liver Disease

  • A. P. Belgaumkar; R. P. Vincent; K. A. Carswell; R. D. Hughes; J. Alaghband-Zadeh; R. R. Mitry; C. W. le Roux; A. G. Patel Changes in Bile Acid Profile After Laparoscopic Sleeve Gastrectomy are Associated with Improvements in Metabolic Profile and Fatty Liver Disease Obes Surg

    Insulin Resistance & Diabetes NAFLD

Roux-en-Y Gastric Bypass Surgery Induces Early Plasma Metabolomic and Lipidomic Alterations in Humans Associated with Diabetes Remission

  • T. Arora; V. Velagapudi; D. J. Pournaras; R. Welbourn; C. W. le Roux; M. Orešič; F. Bäckhed Roux-en-Y Gastric Bypass Surgery Induces Early Plasma Metabolomic and Lipidomic Alterations in Humans Associated with Diabetes Remission PLoS One

    Insulin Resistance & Diabetes

How do patients’ clinical phenotype and the physiological mechanisms of the operations impact the choice of bariatric procedure?

  • T. Bächler; C. W. le Roux; M. Bueter How do patients’ clinical phenotype and the physiological mechanisms of the operations impact the choice of bariatric procedure? Clin Exp Gastroenterol

    Insulin Resistance & Diabetes

Diabetes-associated microbiota in fa/fa rats is modified by Roux-en-Y gastric bypass

  • T. Arora; F. Seyfried; N. G. Docherty; V. Tremaroli; C. W. le Roux; R. Perkins; F. Bäckhed Diabetes-associated microbiota in fa/fa rats is modified by Roux-en-Y gastric bypass Isme j

    Insulin Resistance & Diabetes

Continuous Glucose Monitoring of Glycemic Variability During Fasting Post-Sleeve Gastrectomy

  • E. Al-Ozairi; A. El Samad; J. Al Kandari; E. Taghadom; S. Adam; C. le Roux; A. A. Syed Continuous Glucose Monitoring of Glycemic Variability During Fasting Post-Sleeve Gastrectomy Obes Surg

    Insulin Resistance & Diabetes

Older posts
Newer posts
← Previous Page1 … Page48 Page49 Page50 … Page54 Next →

Recent Posts

  • 9th ASOI Annual Conference – Registration now open!
  • Press Release for World Obesity Day 4th March 2024
  • ASOI and ICPO response to : Medical Council Communication: “Important medicine shortage information – Ozempic (semaglutide)”
  • Things to do in Dublin during ECO
  • ECO 2023 sponsorship update

ASOI

  • info@asoi.info
  • Home
  • ASOI News
  • About Us
  • Events
  • Media Resources
  • Public Resources
  • Guidelines
  • Research
  • Home
  • ASOI News
  • About Us
  • Events
  • Media Resources
  • Public Resources
  • Guidelines
  • Research
  • Privacy Policy
  • Site Map

©2025 ASOI